Oncology and Hematology

Episodes 46-60 of 263

• 

  RestartResume

  Management of HR+, HER2- High-Risk EBC 

  MinuteCE®

  Management of HR+, HER2- High-Risk EBC 

  • 

    

    Erica L. Mayer, MD, MPH

    Peer

  1.50 program credits

• 

  RestartResume

  Management of HER2-Low MBC Following First-Line Disease Progression

  MinuteCE®

  Management of HER2-Low MBC Following First-Line Disease Progression

  • 

    

    Peter Schmid, FRCP, MD, PhD

    Peer

  1.50 program credits

• 

  RestartResume

  Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence     

  MinuteCE®

  Biomarker-Directed Approaches for Frontline Treatment of Advanced Gastric/GEJ Cancers: The Evidence     

  • 

    

    Sara Lonardi, MD

    Peer

  1.25 program credits

• 

  RestartResume

  The Role of Biomarker-Driven Therapies in the Second-Line Treatment of Advanced Gastric/GEJ Cancers: What Do the Data Say?  

  MinuteCE®

  The Role of Biomarker-Driven Therapies in the Second-Line Treatment of Advanced Gastric/GEJ Cancers: What Do the Data Say?  

  • 

    

    Sara Lonardi, MD

    Peer

  1.25 program credits

• 

  RestartResume

  First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study   

  MinuteCE®

  First-Line Advanced Gastric Cancer: Best Practices for Biomarker-Directed Treatment Approaches—A Case Study   

  • 

    

    Sara Lonardi, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence  

  MinuteCE®

  Immunotherapy-Based Approaches for First-Line Treatment of Advanced HCC: The Evidence  

  • 

    

    Alan Venook, MD

    Peer

  1.25 program credits

• 

  RestartResume

  First-line Treatment of MSI-H/dMMR mCRC: The Role of Immunotherapy

  MinuteCE®

  First-line Treatment of MSI-H/dMMR mCRC: The Role of Immunotherapy

  • 

    

    Aparna R. Parikh, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Current Guideline Recommendations for Biomarker-Based Second-Line Treatment of mCRC

  MinuteCE®

  Current Guideline Recommendations for Biomarker-Based Second-Line Treatment of mCRC

  • 

    

    Aparna R. Parikh, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion

  MinuteCE®

  Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion

  • 

    

    Aparna R. Parikh, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Emerging Directions in Biomarker-Directed Therapy for GI Malignancies

  MinuteCE®

  Emerging Directions in Biomarker-Directed Therapy for GI Malignancies

  • 

    

    Alan Venook, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Novel Neoadjuvant and Adjuvant Immunotherapy Strategies for GI Malignancies: The Evidence   

  MinuteCE®

  Novel Neoadjuvant and Adjuvant Immunotherapy Strategies for GI Malignancies: The Evidence   

  • 

    

    Alan Venook, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Expert Opinion: Key Insights on GI Malignancies—Integrating NCCN Clinical Practice Guidelines Into Practice

  MinuteCE®

  Expert Opinion: Key Insights on GI Malignancies—Integrating NCCN Clinical Practice Guidelines Into Practice

  • 

    

    Sara Lonardi, MD

    Peer

  • 

    

    Aparna R. Parikh, MD

    Peer

  • 

    

    Alan Venook, MD

    Peer

  1.25 program credits

• 

  RestartResume

  Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection

  CME/CE

  Advancing ALK Inhibition Into Early-Stage NSCLC: Integrating Biomarker-Driven Therapies to Reduce Recurrence Risk Post Resection

  • 

    

    Mark Socinski, MD

    Peer

  0.25 credits

• 

  MinuteCE®

  Innovations in Oncology Learning Center From Guidelines to Practice: Genitourinary Cancers

  • 

    

    Ignacio Duran, MD

    Peer

  • 

    

    Wenxin Xu, MD

    Peer

  • 

    

    Sandy Srinivas, MD

    Peer

  1.25 credits 10 episodes

• 

  MinuteCE®

  Innovations in Oncology Learning Center From Guidelines to Practice: Gynecologic Cancer

  • 

    

    Susana Campos, MD, MPH

    Peer

  • 

    

    Nicoletta Colombo, MD

    Peer

  • 

    

    Ritu Salani, MD, MBA

    Peer

  1.00 credits 10 episodes

• Prev
• 1
• 2
• 3
• 4
• 5
• 6
• …
• 17
• 18
• Next